This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

South American Thoracic Stent-Graft Study

This study has been completed.
Information provided by (Responsible Party):
TriVascular, Inc. Identifier:
First received: March 4, 2010
Last updated: November 8, 2012
Last verified: November 2012
A prospective, non-randomized multi-center clinical evaluation of the performance of the TriVascular Thoracic Stent Graft System when used in the treatment of subjects with thoracic aortic aneurysms (TAA).

Condition Intervention Phase
Thoracic Aortic Aneurysm Device: Implant Thoracic Stent Graft Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Pilot Trial to Evaluate the Performance of the TriVascular Thoracic Stent Graft System

Resource links provided by NLM:

Further study details as provided by TriVascular, Inc.:

Primary Outcome Measures:
  • Absence of device-related serious adverse events within 30-days of endovascular procedure [ Time Frame: 30-Days ]

Enrollment: 2
Study Start Date: November 2009
Study Completion Date: May 2011
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Implant Thoracic Stent Graft
    Endovascular implant of Thoracic Aortic Aneurysm Stent Graft

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • The TriVascular Thoracic Stent Graft System is indicated in subjects diagnosed with an aneurysm in the descending thoracic aorta having vascular morphology suitable for endovascular repair, including:

    • Adequate iliac/femoral access compatible with the required delivery systems,
    • Non-aneurysmal aortic segments proximal and distal to the aneurysm.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01082172

Pontificia Universidad Caolica de Chile
Santiago, Chile
Sponsors and Collaborators
TriVascular, Inc.
  More Information

Additional Information:
Responsible Party: TriVascular, Inc. Identifier: NCT01082172     History of Changes
Other Study ID Numbers: 771-0001 TAA Trial
Study First Received: March 4, 2010
Last Updated: November 8, 2012

Keywords provided by TriVascular, Inc.:

Additional relevant MeSH terms:
Aortic Aneurysm
Aortic Aneurysm, Thoracic
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases processed this record on September 19, 2017